Loading institutional data...
Loading institutional data...
Held by 349 of 5,944 reporting institutions (95th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Ranked against 1111 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | $1.05T | 51.0× | — | 16.1× | 44.7% | 83.0% | 31.7% | 77.8% | 29.9% | — | 4,193 |
| AKTX | $679.0B | — | — | — | — | — | — | -61.1% | -61.1% | — | 1 |
| JNJ | $620.1B | 23.4× | — | 6.6× | 6.0% | 67.9% | 28.5% | 32.9% | 20.7% | — | 4,451 |
| ABBV | $435.4B | 104.3× | 31.4× | 7.1× | 8.6% | 70.2% | 6.9% | -129% | 6.6% | 4.2× | 3,895 |
| UNH | $374.0B | 31.2× | 21.4× | 0.8× | 11.8% | 88.7% | 2.7% | 12.0% | 6.8% | 3.9× | 2,891 |
| BDRX | $359.1B | — | — | — | — | — | — | — | — | — | 7 |
| MRK | $321.1B | 17.6× | — | 4.9× | 1.3% | 74.8% | 28.1% | 34.7% | 17.9% | — | 3,594 |
| NVSEF | $289.9B | — | — | — | — | — | — | — | — | — | 2 |
| AZN | $250.4B | — | — | — | — | — | — | — | — | — | 1,248 |
| AMGN | $219.7B | 28.7× | 18.3× | 6.0× | 10.0% | 67.2% | 21.0% | 89.1% | 13.1% | 3.5× | 3,014 |
| TMO | $217.8B | 32.6× | 28.5× | 4.9× | 3.9% | — | 15.1% | 12.6% | 7.0% | 4.9× | 2,481 |
| ABT | $183.9B | 28.4× | 19.5× | 4.2× | 5.7% | 56.4% | 14.7% | 12.5% | 10.5% | 1.0× | 2,964 |
| GILD | $163.5B | 19.4× | 18.1× | 5.5× | 2.4% | 78.8% | 28.9% | 37.5% | 17.9% | 2.4× | 2,218 |
| PFE | $146.7B | 19.0× | — | 2.3× | -1.6% | 74.3% | 12.4% | 9.0% | 5.1% | — | 2,838 |
| DHR | $141.1B | 39.5× | 29.3× | 5.7× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 2,083 |
| ISRG | $133.2B | 47.7× | 36.6× | 13.2× | 20.5% | 66.0% | 28.4% | 16.0% | 16.0% | — | 2,190 |
| SYK | $128.8B | 40.1× | 21.8× | 5.1× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 2.5× | 2,196 |
| CVS | $126.0B | 71.3× | 12.7× | 0.3× | 7.8% | 45.0% | 0.4% | 2.4% | 2.4% | 0.0× | 1,795 |
| VRTX | $123.1B | 31.6× | 26.9× | 10.3× | 8.9% | 86.2% | 32.9% | 21.2% | 21.2% | — | 1,609 |
| MDT | $110.1B | 23.1× | 11.7× | 3.0× | 8.4% | 65.0% | 13.2% | 9.7% | 9.4% | 0.2× | 2,114 |
| GLAXF | $106.9B | — | — | — | — | — | — | — | — | — | 5 |
| MCK | $102.7B | 22.9× | 16.2× | 0.3× | 12.4% | 3.6% | 1.2% | -219% | 109% | 1.0× | 1,946 |
| SNYNF | $101.3B | — | — | — | — | — | — | — | — | — | 5 |
| HCA | $92.0B | 14.5× | — | 1.2× | 7.1% | — | 9.0% | -113% | 16.8% | — | 1,346 |
| ELV | $86.4B | 15.5× | 14.8× | 0.4× | 12.5% | 89.4% | 2.8% | 12.9% | 7.6% | 4.2× | 1,397 |
| TGTX | $7.7B | 18.0× | 64.1× | 12.6× | 87.3% | 83.7% | 72.6% | 69.0% | 50.0% | 2.0× | 349 |
Peers = companies sharing TGTX's sector (Healthcare) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Cash conversion lags reported earnings — watch accruals. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$25M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 50%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Effective rate ~10.9% on $246M of debt.
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-08-05
Where each multiple sits in its own 15-yr range · 36th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 15-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Returns are margin-driven, not leverage-driven — higher quality.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 2.2× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | — | — | — | 11.8 | 9.5 | 6.0 | 11.7 | 16.3 |
| R&D | 104862.5 | 101434.2 | 109142.1 | 3327.5 | 4501.0 | 32.6 | 28.7 | 26.0 |
| SG&A | 9974.3 | 9886.2 | 70953.9 | 1914.9 | 3428.5 | 52.5 | 46.9 | 37.7 |
| Operating Income | -114736.8 | -111220.4 | -179996.1 | -5154.3 | -7839.0 | 8.8 | 12.7 | 20.0 |
| Income Tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.7 | -55.1 |
| Net Income | -114132.9 | -113730.9 | -183803.3 | -5204.1 | -7120.3 | 5.4 | 7.1 | 72.6 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on TGTX: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
EOD close · as of 2026-08-05 · 15d old
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $616.3M 100.0% | $329.0M 100.0% | $233.7M 100.0% | $2.8M 100.0% | $6.7M 100.0% | $152K 100.0% | $152K 100.0% | $152K 100.0% | $152K 100.0% | $152K 100.0% |
| Cost of Revenue | $100.7M 16.3% | $38.5M 11.7% | $14.1M 6.0% | $265K 9.5% | $790K 11.8% | — | — | — | — | — |
| Research & Development | $160.2M 26.0% | $94.3M 28.7% | $76.2M 32.6% | $125.4M 4501.0% | $222.6M 3327.5% | $165.9M 109142.1% | $154.2M 101434.2% | $159.4M 104862.5% | $102.5M 67455.9% | $69.2M 45547.4% |
| Selling, General & Admin | $232.0M 37.7% | $154.3M 46.9% | $122.7M 52.5% | $95.5M 3428.5% | $128.1M 1914.9% | $107.8M 70953.9% | $15.0M 9886.2% | $15.2M 9974.3% | $16.3M 10744.1% | $9.9M 6505.9% |
| Total Operating Expenses | $493.0M 80.0% | $287.1M 87.3% | $213.0M 91.2% | $195.6M 7024.2% | $351.5M 5254.3% | $273.7M 180096.1% | $169.2M 111320.4% | $174.6M 114836.8% | $118.9M 78200.0% | $79.1M 52053.3% |
| Operating Income | $123.3M 20.0% | $41.9M 12.7% | $20.6M 8.8% | -$218.3M -7839.0% | -$344.8M -5154.3% | -$273.6M -179996.1% | -$169.1M -111220.4% | -$174.4M -114736.8% | -$118.7M -78100.0% | -$79.0M -51953.3% |
| Interest Expense | $26.7M 4.3% | $24.0M 7.3% | $12.6M 5.4% | $10.2M 365.9% | $5.6M 84.3% | $6.3M 4163.8% | $5.3M 3478.3% | $877K 577.0% | $845K 555.9% | — |
| Interest & Investment Income | — | — | — | — | — | — | — | $857K 563.8% | $295K 194.1% | $323K 212.5% |
| Other Income (Expense), net | -$15.9M -2.6% | -$16.3M -5.0% | -$7.6M -3.2% | -$5.5M -197.3% | -$3.3M -49.8% | -$5.8M -3807.2% | -$3.8M -2510.5% | $918K 603.9% | $236K 155.3% | $716K 471.1% |
| Pretax Income | $107.4M 17.4% | $25.6M 7.8% | $13.1M 5.6% | -$223.8M -8036.3% | -$348.1M -5204.1% | -$279K -183.8% | -$173K -113.7% | -$173K -114.1% | -$118K -77.9% | -$78.3M -51482.2% |
| Income Tax Expense | -$339.8M -55.1% | $2.2M 0.7% | $390K 0.2% | $0 0.0% | $0 0.0% | $0 0.0% | $0 0.0% | $0 0.0% | $0 0.0% | $0 0.0% |
| Net Income | $447.2M 72.6% | $23.4M 7.1% | $12.7M 5.4% | -$198.3M -7120.3% | -$348.1M -5204.1% | -$279.4M -183803.3% | -$172.9M -113730.9% | -$173.5M -114132.9% | -$118.5M -77944.7% | -$78.3M -51482.2% |
| Per Share | ||||||||||
| EPS (Basic) | $3.10 | $0.16 | $0.09 | $-1.65 | $-2.63 | $-2.42 | — | — | — | — |
| EPS (Diluted) | $2.77 | $0.15 | $0.09 | $-1.65 | $-2.63 | $-2.42 | — | — | — | — |
| Weighted Avg Shares (Basic) | 144.3M | 145.3M | 142.0M | 135.4M | 132.2M | 115.3M | — | — | — | — |
| Weighted Avg Shares (Diluted) | 161.4M | 160.3M | 148.5M | 135.4M | 132.2M | 115.3M | — | — | — | — |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.